Takeda is interested in the Indian pharmaceutical market

Japan's largest pharmaceutical company, Takeda Pharmaceutical does not preclude the acquisition of Indian drug manufacturers, reports Financial Express. The head of Indian unit appointed Shankar Suryanarayanan, who previously worked for a Swiss company Roche and Novartis. As the President of Takeda, the Japanese company may buy the Indian pharmaceutical producers to start the generic business in developing countries. In 2008, another Japanese pharmaceutical company - Daiichi Sankyo acquired a controlling stake in India's Ranbaxy Laboratories. According to informed sources, referenced in Financial Express, Mr. Suryanarayanan conducting a study of the Indian pharmaceutical market to find larger companies to enter into partnerships or even acquire a minority stake in such companies.